NewsRx

Search our medical news database

Prostate Cancer

Wests MixJect System Selected by Watson for use in Treatment of Prostate Cancer

Published in Medical Verdicts and Law Weekly, July 31st, 2008

West (NYSE: WST), the world's premier manufacturer of components and systems for injectable drug delivery, announced that Watson Pharma, Inc., a subsidiary of Watson Pharmaceuticals, Inc., has selected MixJect® as the new delivery system for TRELSTAR® (triptorelin pamoate for injectable suspension), a palliative treatment for advanced prostate cancer. The MixJect system, developed and manufactured by West's subsidiary Medimop Medical Projects Ltd, is a patented reconstitution device that ensures the safe and easy delivery of lyophilized drugs. West provides the reconstitution system in a kit, also containing the diluent syringe.

As more and more pharmaceuticals enter...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook